The market growth is primarily driven by the rising incidence of infectious diseases coupled with epidemic and pandemic outbreaks, increasing food safety concerns, technological advancements in microbial identification techniques, and government initiatives and funding to promote microbial identification.
Target Audience for this Report:
Academic and research institutes
Hospitals, clinics, and laboratories
Clinical research organizations (CROs)
Microbial identification service providers
Culture collection repositories
Diagnostic associations
Venture capitalists
Life sciences instrumentation and reagent companies
Business research and consulting firms
Government bodies
Microbial identification database and software providers
The global market is segmented by product and service, method, application, end user, and regions.
By product and service, the global market is segmented into instruments, consumables, and services. The instruments segment is estimated to account for the largest market share of the global market in 2017. Factors driving the growth of this segment include the extensive use of instruments and advances in technology to develop innovative instruments.
By method, the market is classified into phenotypic methods, proteomics-based methods, and genotypic methods. The phenotypic methods segment is estimated to account for the largest share of the global microbial identification market. The large share of this segment can be attributed to features like cost-effectiveness, ease of use, and ability to deliver results rapidly which lead to their increased adoption across different end users.
North America will continue to dominate the global market in the forecast period.
The global microbial identification market is dominated by North America, followed by Europe. North America will continue to dominate the global market in the forecast period. However, Asia is expected to witness the highest CAGR, with the growth in this market centered at Japan, China, and India. Factors such as the rising focus of major players in emerging Asian countries and government support are driving the growth of the market in this region.
The factors such as the high cost of instruments and complex regulatory framework for the approval of new microbial diagnostic tests may restrain the market’s growth to a certain extent.
Major industry players launched innovative products to maintain and improve their position in the market. Becton, Dickinson and Company (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), bioMérieux S.A. (France), and Bruker Corporation (US), Eurofins Scientific S.E. (Luxembourg) have been identified as the key players in microbial identification market. These companies have a broad product portfolio with comprehensive features and have also launched innovative products. These leaders also have products for all end users in this market, a strong geographical presence, and they focus on continuous product innovations.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
